跳至主要内容
临床试验/PACTR201602001487159
PACTR201602001487159已完成未知

Study of serum interleukin 17 level in children with bronchial asthma

mohammed sami bazzari0 个研究点目标入组 85 人开始时间: 2016年2月23日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
85

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
4 Year(s) 至 14 Year(s)(—)
性别
All

入选标准

  • Every Asthmatic child had at least three attacks of (paroxysmal dyspnea, cough, and wheeze).
  • Attack was relived spontaneously or with treatment (mainly with beta 2 agonist).
  • Patients had to be completely symptoms free for at least 2 weeks in between attacks.
  • Asthmatic children had to fulfill the criteria of asthmatic diagnosis of GINA guidelines (2014) [6].

排除标准

  • Any patient had been used systemic corticosteroid in order not to affect Interleukin 17 serum level.
  • Patients were diagnosed with any of Asthma differential diagnoses diseases
  • Patients were known as a carrier of a blood transmitted infectious disease or had suffered from conditions in which phlebotomy was contraindicated.

研究者

发起方
mohammed sami bazzari

相似试验